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Recent Advances of Oral Rehydration Therapy (ORT)
Diarrheal disease is one of the leading causes of worldwide morbidity and 
mortality, especially in children. It causes loss of body fluid, which may lead 
to severe dehydration, electrolyte imbalance, shock and even to death. The 
mortality rate from acute diarrhea has decreased over the last few decades. 
This decline, especially in developing countries is largely due to the implantation 
of the standard World Health Organization-oral rehydration solution (WHO-
ORS). However, the use of standard ORS has been limited by its inability to 
reduce fecal volume or diarrhea duration. Subsequently, this has led to various 
attempts to modify its compositions. And these modifications include the use of 
reduced osmolarity ORS, polymer-based ORS and zinc supplementation. Some 
of these variations have been successful and others are still under investigation. 
Therefore, further trials are needed to progress toward the ideal ORS. In this 
article, we briefly reviewed the pathophysiologic basis of the ORS, followed by 
the standard WHO-ORS and several modifications to improve the ORS.
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Introduction 
Acute diarrhea is a major problem worldwide, although 
the overall mortality rate from diarrheal disease has 
steadily declined over the last few decade
1). The critical 
factor for the reduction in the mortality from diarrhea was 
the introduction of oral rehydration therapy (ORT). The 
standard World Health Organization oral rehydration 
solution (WHO-ORS) was initially assessed for cholera 
treatment, and then shown to be effective irrespective 
of cause of diarrhea or age of the patient
2). However, the 
WHO-ORS does not substantially decrease either stool 
volume or the duration of diarrhea episodes
3). As a result, 
improved ORSs for enhancing treatment of acute diarrhea 
continually have been sought for and evaluated. 
Pathophysiologic basis for using ORS
In an adult, the daily intestinal water load is approxi-
mately 6,500 mL from the combination of oral intake, 
gastric juices and pancreaticobiliary juices, as well as an 
additional 1,000 mL secreted by the upper intestine. This 
volume is reduced to 1,500 mL by the distal ileum and 
is further reduced in the colon to a stool output of 250 
mL per day
4). The net absorption of water and ions is the 
result of two opposing unidirectional fluxes of ions, one 
absorptive and the other secretory. And the two processes 
are anatomically separated: absorption takes place mainly 
in the mature villous cells, whereas secretion seems to occur 
in the crypt cells
5). In normal circumstances, absorptive 
processes for water and electrolytes prevail over secretory 
processes and as a result, water is absorbed. However, 
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during diarrheal disease, there is a derangement in the 
absorptive-secretory processes by osmotic and/or secretory 
mechanisms. The absorption of water and nutrients is 
dependent on the osmotic gradient dictated by sodium 
transport via the following three mechanisms: neutral NaCl 
absorption, sodium absorption coupled to the absorption 
of organic solutes such as glucose and amino acids, and 
electrogenic sodium absorption
5). In diarrheal disease, 
disruption of these processes occurs except the sodium 
absorption coupled glucose and other organic solutes, 
even in enteritis associated with epithelial damage
6, 7). The 
preservation of this facilitated cotransporter of glucose and 
sodium is the scientific rationale for the development of the 
ORS. By this intact Na
+/glucose cotransporter, unaffected 
by pathologic processes that induce secretion, sodium 
and water are absorbed and in turn, extracellular fluid is 
expanded without change in serum osmolarity
8). 
Efficacy of ORS
ORS has several advantages compared with intravenous 
fluid therapy (IVT). It is convenient to administrate and 
does not accompany pain or phlebitis. Moreover, based 
on the results of meta-analyses of randomized controlled 
studies
9, 10), the effectiveness of the ORS has been shown to 
be similar with intravenous rehydration for treating acute 
gastroenteritis in children. There was no difference in the 
frequency of stool, duration of diarrhea, weight gain or 
development of hypo or hypernatremia between the ORS 
group and the IVT group. In addition, there was a shorter 
hospital stay in the ORS group. However, paralytic ileus 
occurred more frequently in the ORS group. According to 
these results, the ORT has advantages in all aspects except 
the development of paralytic ileus compared with IVT.
Standard WHO-ORS 
In 1975, the WHO first introduced an ORS that sub-
sequently has been used throughout the world for more 
than 25 years. This ORS was initially designed to treat 
children with diarrhea from cholera. The standard WHO-
ORS has an osmolarity of 311 mOsm/L and concentrations 
of sodium at 90 mEq/L, potassium at 20 mEq/L, chloride at 
80 mEq/L and glucose at 20 g/L
11). However, subsequently, 
it became clear that the composition of the standard WHO-
ORS could not be optimized to help reduce the volume 
of stool and duration of diarrhea, although hydrational 
status could be maintained
3). The concentration of sodium 
was too high for well-nourished children with noncholeral 
diarrhea
12). This has led to a search for an ORS with im-
proved compositions. 
Reduced osmolarity ORS
Animal studies
13) and in vivo human intestinal studies
14) 
have shown that reduced osmolarity ORS resulted in 
increased water absorption when compared with the 
standard ORS in acute non-cholera diarrhea. Similar 
observations have been reported in human studies
15, 16). 
In a meta-analysis by Hahn et al.
17), the effectiveness and 
complications of reduced–osmolarity ORS (osmolarity 
less than 250 mOsm/L) was compared with those of the 
standard WHO-ORS in 2,397 patients with acute diarrhea 
of less than 5 days duration. This study included 12 trials 
of non-cholera patients and 3 of cholera patients. They 
concluded that there were reductions in stool output, 
episodes of vomiting and the need for intravenous hydration 
in the reduced-osmolarity ORS group. Furthermore, on the 
basis of the results in 6 trials measuring serum sodium values 
with events in 3 studies, the incidence of hyponatremia 
was not different between both groups
18). According to this 
finding, the WHO changed its recommendations for acute 
non-cholera diarrhea in children; the composition of the 
ORS to a lower osmolarity (245 mOsm/L) and to lower 
concentrations of glucose (13.5 g/L) and sodium (75 mEq/
L)
19).
However, the optimal osmolarity is still debated, 
especially in adult patients with cholera
5). Although there 
was no additional risk of hyponatremia in children receiving 
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cholera may be necessary if a single ORS formulation is to 
be used for cholera and noncholera patients
5).  
Polymer-based ORS
The substitution of glucose monomer in the ORS with 
glucose polymers such as whole rice and wheat has been 
evaluated as a method to decrease both the volume and 
duration of diarrhea
20, 21). The aim for this is to slowly 
release glucose into the gut and improve the absorption 
of water and salt in the solution
22, 23). A recently published 
meta-analysis by Gregorio et al.
24) compared polymer-based 
ORS with glucose-based ORS for treating acute watery 
diarrhea. This study included 34 trials involving 4,214 
participants with diarrhea (27 trials in children, 5 in adults 
and 2 in both) and most compared polymer-based ORS 
with high-osmolarity ORS (more than 310 mOsm/L). They 
concluded that polymer-based ORS was judged superior to 
the WHO-ORS in the treatment of diarrhea of all causes 
overall, and specifically in the treatment of cholera-induced 
diarrhea, in terms of fewer unscheduled intravenous 
infusions and shortened diarrhea duration. However, the 
analysis was underpowered to favor polymer-based ORS 
over reduced osmolarity ORS, and further trials against 
the current standard (ORS with osmolarity less than 250 
mOsm/L) are required. 
Zinc supplementation
Diarrhea can lead to zinc deficiency, and the resulting 
zinc deficiency can lead to a vicious cycle of worsening 
duration and severity of diarrhea
25). The beneficial 
effects of zinc include improved cellular immunity and 
maintenance of gut mucosal cells
26). The effectiveness of 
zinc for treating diarrhea has been evaluated in several 
studies
27-29). Baqui AH et al.
29) reported a 24% reduction in 
diarrhea-related hospitalization rate and overall decrease 
in mortality. In a meta-analysis of 16 trials that included 
15,231 participants with acute diarrhea and 6 trials that 
included 2,968 participants with persistent diarrhea
30), 
zinc supplementation resulted in a reduction of the mean 
duration of both acute and persistent diarrhea as well as a 
reduction in stool frequency. However, its supplementation 
was associated with a greater incidence of vomiting in 11 
of the acute diarrhea trials and in 4 persistent diarrheal 
trials
30). Based on the proven safety and effectiveness of 
zinc supplementation as an adjunct therapy for diarrhea, 
the WHO recommends oral zinc for 10–14 days at 20 mg 
per day in children older than 6 months and 10 mg per 
day in children younger than 6 months for acute diarrheal 
illness
19). There are no specific recommendations for zinc 
supplementation for adults because of a paucity of data 
from adults, although the mechanism of action would 
presumably be the same
19). 
Commercial ORS 
Commercially available ORS vary in osmolarity and 
sodium concentration (Table 1). Studies in the United States 
showed that children with mild to moderate dehydration 
were treated successfully with commonly used commercial 
ORS
31, 32). In children between 5 and 10 years of age, 
sucralose-sweetened ORSs (for example, Pedialyte and 
Pediatric Electrolyte) appear to be more palatable than 
comparable rice-based solutions such as Enfalyte
33). Other 
nonphysiologic fluids such as sports drinks and soft drinks 
have too little sodium and much higher osmolarity than 
recommended. These fluids are not suitable for diarrheal 
treatment as they may cause osmotic diarrhea and 
hyponatremia (Table 1). 
Conclusion
ORS has been used successfully in the treatment 
of diarrheal illness and has resulted in a reduction in 
childhood mortality from diarrhea. The standard WHO-
ORS has been used to replace water and electrolytes lost 
in stools, but it does not decrease diarrhea duration or the 
stool volume. This has led to search for modified ORSs with 
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in that it has been found to decrease the fecal volume and 
duration of diarrhea. Because of that, it is currently used 
as a recommended ORS formulation by the WHO for the 
treatment of acute non-cholera diarrhea. The addition of 
zinc supplementation is recommended by WHO in the 
treatment of acute diarrhea. Polymer-based ORS seems 
to be superior than the standard WHO-ORS for treating 
acute diarrhea, but further studies against the current 
reduced osmolarity ORS are needed.    
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